MSTR sells 32 BTC for the first time to pay preferred dividends; CME launches 24/7 crypto derivatives

iconKuCoinFlash
Share
Share IconShare IconShare IconShare IconShare IconShare IconCopy
AI summary iconSummary

expand icon
BTC news today: MSTR sold 32 BTC at $77,135 each, totaling $2.5 million, to pay preferred dividends—its first BTC update since 2020. CME launched 24/7 crypto derivatives on May 29, including BTC Volatility Futures. Over 7,200 contracts traded during the first weekend, valued at $50 million.

ME News report, June 2 (UTC+8): According to comprehensive disclosure from BBX crypto-related stock information, yesterday marked two significant developments: one being a maturity signal in capital structure with the first-ever BTC-backed physical dividend issued by the largest BTC treasury company, and the other being a market structure upgrade with regulated derivatives infrastructure achieving 24/7 synchronization with the crypto spot market for the first time.

Key Updates Quick Recap

Strategy Inc. (NASDAQ: MSTR) June 1 Form 8-K: Between May 26 and 31, the company sold 32 BTC at a net average price of approximately $77,135 per BTC, generating total net proceeds of about $25 million; the proceeds are expected to be entirely used for preferred stock dividend payments. As of May 31, the total holdings decreased to 843,706 BTC (a reduction of 32 BTC from 843,738 BTC on May 25), with a total cost basis of $6.387 billion and an average cost of approximately $75,699 per BTC. This marks the first sale since Strategy began systematically accumulating Bitcoin in August 2020, signifying the company’s capital structure has evolved into a new phase where physical BTC holdings are liquidated to support preferred stock dividends, representing the first practical implementation of CEO Phong Le’s previously stated “dynamic, multi-variable capital allocation model.” The May 26 Form 8-K previously disclosed that the USD Reserve had declined to $871 million; this Form 8-K simultaneously updates the USD Reserve movement (final balance subject to confirmation in official filings).

CME Group Inc. (NASDAQ: CME), in an official PRNewswire release on June 1, announced that its global leading derivatives exchange has successfully launched 24/7 trading for cryptocurrency futures and options, effective Friday, May 29. During the first weekend (May 29 to June 1), over 7,200 cryptocurrency futures and options contracts were traded, with a notional value of approximately $500 million. Simultaneously, CME launched Bitcoin Volatility Futures (BVI)—the first regulated futures product tracking Bitcoin’s 30-day implied volatility—enabling investors to manage volatility risk without taking directional Bitcoin positions. CME’s current cryptocurrency offerings include Bitcoin, Ethereum, and Solana futures and options, all accessible 24/7 via the CME Globex platform (with a two-hour weekly maintenance window). Background: CME’s full-year 2025 notional cryptocurrency derivatives trading volume reached $3 trillion; from 2026 through today, average daily contract volume stands at 407,200 contracts (+46% year-over-year); the company’s market capitalization is approximately $93.9 billion. Upcoming: The Nasdaq CME Cryptocurrency Index Futures is scheduled to launch on June 8 (subject to regulatory approval), becoming CME’s first market-cap-weighted multi-cryptocurrency index futures product.(Source: BBX)

Disclaimer: The information on this page may have been obtained from third parties and does not necessarily reflect the views or opinions of KuCoin. This content is provided for general informational purposes only, without any representation or warranty of any kind, nor shall it be construed as financial or investment advice. KuCoin shall not be liable for any errors or omissions, or for any outcomes resulting from the use of this information. Investments in digital assets can be risky. Please carefully evaluate the risks of a product and your risk tolerance based on your own financial circumstances. For more information, please refer to our Terms of Use and Risk Disclosure.